Rheonix
PrivateLast Round
Debt
Jun 18, 2020
Total Funding Raised
$49.55M
Company Overview
Rheonix is a biotechnology company that develops automated molecular diagnostics platforms and assays for clinical, research, and applied testing markets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheonix Comparables
Compare Rheonix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biocartis | 77% | |
| Clear Labs | 76% | |
| Danaher Corporation | 75% | |
Rheonix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 18, 2020 | ||||
| Grant | Apr 19, 2016 | ||||
| Series B | Oct 20, 2015 | ||||
| Grant | Feb 10, 2015 | ||||
| Grant | Apr 21, 2014 | ||||
VC Round | Dec 19, 2013 |
Rheonix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Limestone Capital Advisors | Series B |
| NIH RADx | Grant |
| Advantage Capital | Series B |
| Onondaga Venture Capital Fund | Series A, Series B |
| National Institute of Dental and Craniofacial Research | Grant |
| Cayuga Venture Fund | Series A, VC Round, Series B |
| Rand Capital BDC | Series A, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2016
$656K grant received from NIH and NIDCR.
- Oct 20, 2015
$29M round led by Advantage Capital and Cayuga Venture Fund.
Rheonix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rheonix's valuation, stock price, and market status.